Cormorant Asset Management’s Rain Oncology Inc. Common Stock RAIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,978,660
| Closed | -$26M | – | 78 |
|
|
2023
Q1 | $26M | Hold |
2,978,660
| – | – | 1.71% | 16 |
|
|
2022
Q4 | $23.8M | Buy |
2,978,660
+652,000
| +28% | +$5.22M | 1.59% | 22 |
|
|
2022
Q3 | $11.4M | Hold |
2,326,660
| – | – | 0.79% | 38 |
|
|
2022
Q2 | $12.9M | Hold |
2,326,660
| – | – | 0.98% | 33 |
|
|
2022
Q1 | $11.8M | Hold |
2,326,660
| – | – | 0.91% | 32 |
|
|
2021
Q4 | $30M | Hold |
2,326,660
| – | – | 1.78% | 17 |
|
|
2021
Q3 | $34.8M | Sell |
2,326,660
-300,000
| -11% | -$4.49M | 1.41% | 20 |
|
|
2021
Q2 | $39.7M | Buy |
+2,626,660
| New | +$39.7M | 1.35% | 23 |
|